市場調査レポート
商品コード
1211042
移植の世界市場規模調査・予測:製品別、用途別、エンドユーザー別、地域別分析、2022-2029年Global Transplantation Market Size study & Forecast, by Product by Application, by End User and Regional Analysis, 2022-2029 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
移植の世界市場規模調査・予測:製品別、用途別、エンドユーザー別、地域別分析、2022-2029年 |
出版日: 2023年01月25日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界の移植市場は、2021年に約124億米ドルと評価され、予測期間2022-2029年には9.4%以上の健全な成長率で成長すると予想されています。
移植は、個人の体から臓器を切り離し、レシピエントの体に設置する外科的方法と呼ばれています。一般的には、組織移植と臓器移植の2種類が行われています。臓器不全の症例が増加していること、組織バンクの開拓が進んでいること、そして償還の枠組みが、世界中の市場需要を規定する主要な要因となっています。
慢性疾患とそれに伴う臓器不全の発生率が高いため、移植手術の需要は常に高まっています。保健社会福祉省によると、2019年に移植用臓器の提供を待つ患者は、米国全体で約122,913人です。同様に、臓器調達・移植ネットワーク(OPTN)の予備データでは、2021年に米国で実施された臓器移植は約41,354件と推定され、2020年と比較して5.9%増加したと報告されています。このように、人口の間で移植手術の必要性が高まっていることが、世界中で市場需要を促進しています。さらに、組織製品の技術的進歩の高まりや、新たな適応症に対するFDA承認の増加が、予測期間中にさまざまな有利な機会をもたらしています。しかし、臓器提供者の不足と倫理的・文化的問題が、2022~2029年の予測期間を通じて市場成長の妨げになる構えです。
世界の移植市場の調査において考慮された主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、その他の地域です。北米が収益面で市場を独占したのは、医療施設がよく整備されていることと、現地市場に多くの大手バイオテクノロジー企業や医療機器企業が存在するためです。一方、アジア太平洋地域は、体外組織や臓器の開発のための幹細胞に関する研究の増加や、アジア諸国における医療インフラの開発により、予測期間中に最も高いCAGRで成長すると予想されます。
本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
Global Transplantation Market is valued at approximately USD 12.4 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.4% over the forecast period 2022-2029. Transplantation is referred as a surgical method in which an organ is detached from an individual's body and placed in the recipient's body. There are two common type of transplantation are performed that are tissue transplantation and organ transplantation. The rising cases of organ failure, a growing development of tissue banks, coupled with the reimbursement framework are the primary factors that are stipulating the market demand across the globe.
The demand for transplantation procedures is constantly growing owing to the high incidences of chronic diseases and related organ failure. As per the Department of Health & Human Services, approximately 122,913 patients across the United States waiting to receive organs for transplant in 2019. Likewise, the preliminary data from the Organ Procurement and Transplantation Network (OPTN) reported that, in 2021, it was estimated that there were around 41,354 organ transplants were performed in the U.S., which is a rise of 5.9% compared to 2020. Thus, the growing requirement for transplantation procedures among the population is fueling the market demand across the globe. Moreover, the rising technological advancements in tissue products, as well as the increasing FDA approvals for new indications are presenting various lucrative opportunities over the forecasting years. However, the scarcity of organ donors and ethical and cultural issues are poised to hinder market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Transplantation Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue because of the well-developed healthcare facilities and the presence of many large biotechnology and medical device companies in the local market. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to increased research on stem cells for the development of in-vitro tissue and organs, as well as developing healthcare infrastructure in Asian countries.
Major market players included in this report are:
Abbvie, Inc
Arthrex, Inc.
Zimmer Biomet
Medtronic
Novartis AG
Strykers
21st Century Medicine
BiolifeSolutions, Inc
Teva Pharmaceuticals
Veloxis Pharmaceutical
Recent Developments in the Market:
Global Transplantation Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product, Application, End User, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Tissue Products
Immunosuppressive Drugs
Preservation Solution
By Application:
Organ Transplantation
Tissue Transplantation
By End User:
Hospitals
Transplant Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World